Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
388.00
2,835.00
987.00
2,042.00
1,485.00
1,788
Cost of Goods Sold (COGS) incl. D&A
1,176.00
3,489.00
1,405.00
-
-
-
Gross Income
788.00
654.00
418.00
-
-
-
SG&A Expense
43,720.00
42,604.00
37,516.00
39,823.00
23,841.00
17,824
EBIT
44,508.00
43,258.00
37,934.00
-
22,548.00
16,195
Unusual Expense
761.00
3,791.00
12,807.00
223.00
5,824.00
3,345
Non Operating Income/Expense
-
-
150.00
823.00
129.00
401
Interest Expense
1,471.00
4,597.00
4,583.00
2,518.00
1,863.00
1,409
Pretax Income
45,215.00
44,058.00
55,170.00
39,490.00
18,446.00
20,533
Consolidated Net Income
45,215.00
44,058.00
55,170.00
39,490.00
18,446.00
33,038
Net Income
45,215.00
44,058.00
55,170.00
39,490.00
18,446.00
33,038
Net Income After Extraordinaries
45,215.00
44,058.00
55,170.00
39,490.00
18,446.00
33,038
Net Income Available to Common
45,215.00
44,058.00
55,170.00
39,490.00
24,816.00
34,756
EPS (Basic)
229.11
155.74
158.38
94.93
24.14
7.74
Basic Shares Outstanding
197.40
303.90
348.30
416.00
1,028.00
4,493
EPS (Diluted)
229.11
155.74
160.82
94.93
24.14
7.74
Diluted Shares Outstanding
197.40
307.20
348.30
416.00
1,028.00
4,493
EBITDA
43,801.00
42,440.00
37,222.00
37,781.00
22,356.00
16,036
Non-Operating Interest Income
3.00
6.00
4.00
18.00
12.00
15
Preferred Dividends
-
-
-
-
6,370.00
1,718

About Windtree Therapeutics

View Profile
Address
2600 Kelly Road
Warrington Pennsylvania 18976
United States
Employees -
Website http://www.windtreetx.com
Updated 07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.